{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:12:25Z","timestamp":1788772345828,"version":"build-2803163510"},"reference-count":17,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Ozanimod is approved for the treatment of ulcerative colitis (UC). The aim of the present study was to evaluate the clinical, biochemical, and endoscopic outcomes. Materials and Methods: This was a retrospective, multicenter, cohort study. Clinical, biochemical, endoscopic, and safety data were collected from medical records. \u03a4he primary outcome was clinical response at week 12. Secondary outcomes included clinical remission, endoscopic improvement and remission, biochemical outcomes, treatment persistence, and safety. Clinical outcomes were assessed at weeks 12 and 48, while treatment persistence was evaluated over the complete 48-week follow-up period, using Kaplan\u2013Meier analysis. Clinical response was defined as a \u226530% reduction in partial Mayo score and remission as a partial Mayo score &lt; 3, with no individual sub-score &gt; 1 and a rectal bleeding sub-score of 0. Clinical response and remission were primarily assessed using an observed-case approach, with an additional sensitivity analysis classifying discontinuations due to lack of efficacy as treatment failures. Results: A total of 79 patients were included (62.0% male; median age 44 years, IQR 31\u201356). Prior biologic exposure was recorded in 29.1%, and 64.6% were previously exposed to oral corticosteroids. Among patients with available clinical assessment at week 12 (n = 62), clinical response and clinical remission were achieved in 77.4% and 71.0%, respectively. Among patients with available data at week 12 (n = 32), endoscopic improvement was observed in 65.6%, while endoscopic remission was achieved in 15.6%. At week 48, among 26 evaluable patients, clinical response and remission rates were 96.2% and 84.6%, respectively; when discontinuations due to lack of efficacy were considered treatment failures, the corresponding rates were 52.1% and 45.8%. Treatment persistence did not differ significantly according to overall prior biologic exposure, whereas previous vedolizumab exposure was associated with lower treatment persistence over the week 48 follow-up (log-rank p = 0.037). In multivariable Cox regression, previous vedolizumab exposure remained associated with an increased hazard of treatment discontinuation (adjusted HR 3.07, 95% CI 1.23\u20137.67; p = 0.016). Adverse events were reported in 13.9% of patients. Conclusions: Ozanimod demonstrated good efficacy and a favorable safety profile in patients with moderate UC.<\/jats:p>","DOI":"10.3390\/medicina62091711","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:07:06Z","timestamp":1788768426000},"page":"1711","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Ozanimod in Ulcerative Colitis: A Real-World Pan-Hellenic Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3424-808X","authenticated-orcid":false,"given":"Pavlos","family":"Pardalis","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, \u201cAlexandra\u201d General Hospital of Athens, 115 28 Athina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-6092","authenticated-orcid":false,"given":"Alexandros","family":"Ioannou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, \u201cAlexandra\u201d General Hospital of Athens, 115 28 Athina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Delidis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, \u201cAlexandra\u201d General Hospital of Athens, 115 28 Athina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9640-6634","authenticated-orcid":false,"given":"Georgios","family":"Kokkotis","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, 3rd Academic Department of Internal Medicine, University of Athens-Sotiria Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Leonidakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, \u201cAlexandra\u201d General Hospital of Athens, 115 28 Athina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Axiaris","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Theagenio Cancer Hospital of Thessaloniki, 546 39 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-9678","authenticated-orcid":false,"given":"Konstantinos","family":"Argyriou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University General Hospital of Larissa, 413 34 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthia","family":"Gatopoulou","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, General University Hospital of Alexandroupolis, 681 00 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Giouleme","sequence":"additional","affiliation":[{"name":"2nd Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1606-5232","authenticated-orcid":false,"given":"Nikolaos","family":"Kalakos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, General Hospital G. Gennimatas, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Karatzas","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, General Hospital Laiko, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8579-0627","authenticated-orcid":false,"given":"Ioanna Nefeli","family":"Mastorogianni","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University Hospital and University of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kapsoritakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University General Hospital of Larissa, 413 34 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrosini","family":"Laoudi","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, 3rd Academic Department of Internal Medicine, University of Athens-Sotiria Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7345-5298","authenticated-orcid":false,"given":"Panagiotis","family":"Markopoulos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Metaxa Cancer Hospital of Athens, 185 37 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University Hospital and University of Ioannina, 455 00 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-6777","authenticated-orcid":false,"given":"Georgios","family":"Michalopoulos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, General Hospital G. Gennimatas, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8141-9755","authenticated-orcid":false,"given":"Konstantinos","family":"Mousourakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Evangelismos Hospital, 106 76 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-5717","authenticated-orcid":false,"given":"Georgios","family":"Bamias","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, 3rd Academic Department of Internal Medicine, University of Athens-Sotiria Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3518-4060","authenticated-orcid":false,"given":"Georgios","family":"Papatheodoridis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, General Hospital Laiko, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Papatzelou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital, 715 00 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8635-6400","authenticated-orcid":false,"given":"Konstantinos","family":"Soufleris","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Theagenio Cancer Hospital of Thessaloniki, 546 39 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-0878","authenticated-orcid":false,"given":"Maria","family":"Tzouvala","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, General Hospital Nikaia and Pireaus \u201cAgios Panteleimon\u201d, 184 54 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftychia","family":"Tsironi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Metaxa Cancer Hospital of Athens, 185 37 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Psaroudakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Venizeleio General Hospital, 714 09 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Theodoropoulou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Venizeleio General Hospital, 714 09 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Varka","sequence":"additional","affiliation":[{"name":"2nd Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0918-1587","authenticated-orcid":false,"given":"Nikos","family":"Viazis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Evangelismos Hospital, 106 76 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8154-0444","authenticated-orcid":false,"given":"Eirini","family":"Zacharopoulou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, General Hospital Nikaia and Pireaus \u201cAgios Panteleimon\u201d, 184 54 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3552-3074","authenticated-orcid":false,"given":"Konstantinos","family":"Karmiris","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital, 715 00 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2773-2709","authenticated-orcid":false,"given":"Ioannis","family":"Koutroubakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital, 715 00 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7371-8601","authenticated-orcid":false,"given":"Spyridon","family":"Michopoulos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, \u201cAlexandra\u201d General Hospital of Athens, 115 28 Athina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-1350","authenticated-orcid":false,"given":"Evanthia","family":"Zampeli","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, \u201cAlexandra\u201d General Hospital of Athens, 115 28 Athina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Eckmann","year":"2012","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management","volume":"11","author":"Harbord","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/ecco-jcc\/jjy004","article-title":"Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: A systematic review and meta-analysis","volume":"12","author":"Singh","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s40265-020-01319-7","article-title":"Ozanimod: First Approval","volume":"80","author":"Lamb","year":"2020","journal-title":"Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","article-title":"Ozanimod as induction and maintenance therapy for ulcerative colitis","volume":"385","author":"Sandborn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","first-page":"2942","article-title":"Long-term efficacy and safety of ozanimod in moderately to severely active ulcerative colitis: Results from the True North open-label extension study","volume":"21","author":"Sandborn","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s40265-022-01762-8","article-title":"Ozanimod: A Review in Ulcerative Colitis","volume":"82","author":"Paik","year":"2022","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.14309\/ajg.0000000000003310","article-title":"Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial","volume":"120","author":"Sands","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: A systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"otad045","DOI":"10.1093\/crocol\/otad045","article-title":"Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients with Ulcerative Colitis Initiated on Ustekinumab in the United States","volume":"5","author":"Zhdanava","year":"2023","journal-title":"Crohns Colitis 360"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"jjaf231.780","DOI":"10.1093\/ecco-jcc\/jjaf231.780","article-title":"Ustekinumab has the highest persistence in Crohn\u2019s Disease, vedolizumab has the highest persistence in Ulcerative Colitis, and persistence declines from first- to fourth-line therapy","volume":"20","author":"Gu","year":"2026","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.cgh.2024.03.042","article-title":"Ozanimod in Patients with Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies","volume":"22","author":"Sands","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10620-023-08178-8","article-title":"Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center","volume":"69","author":"Cohen","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"i507","DOI":"10.1093\/ecco-jcc\/jjac190.0506","article-title":"Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: A phase 3 True North post hoc analysis","volume":"17","author":"Sands","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ecco-jcc\/jjad146","article-title":"Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension","volume":"18","author":"Danese","year":"2024","journal-title":"J. Crohns Colitis"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1711\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:59:53Z","timestamp":1788771593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medicina62091711"],"URL":"https:\/\/doi.org\/10.3390\/medicina62091711","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]}}}